ACA Portfolio, Winners and Losers Affordable Care Act (ObamaCare)

Stock Symbol
Industry
Insurance
WLP
UNH
CI
Drug Distributors
CVS
WAG
ABC
MCK
CAH
Hospitals
HCA
CYH
HMA
VHS
THC
Pharmaceuticals
ABT
LLY
MRK
PFE
JNJ
Medical Device
ISRG
MDT
Biotechnology
IBB
GILD
CELG
AMGN
High Risk
ILMN
ONVO
MJNA
HMSY
HEPI
Portfolio % Dollar Amount

# of shares
Stock Price 01/02/2013
10%
$100,000.00
3.33%
$33,333.33
545.7323728 $
61.08
3.33%
$33,333.33
607.3858115 $
54.88
3.33%
$33,333.33
616.1429452 $
54.10
20%
$200,000.00
4.00%
$40,000.00
815.9934721 $
49.02
4.00%
$40,000.00
1056.524036 $
37.86
4.00%
$40,000.00
917.6416609 $
43.59
4.00%
$40,000.00
408.3716182 $
97.95
4.00%
$40,000.00
963.6232233 $
41.51
20%
$200,000.00
4.00%
$40,000.00
1305.057096 $
30.65
4.00%
$40,000.00
1267.427123 $
31.56
4.00%
$40,000.00
4210.526316 $
9.50
4.00%
$40,000.00
3189.792663 $
12.54
4.00%
$40,000.00
1205.908954 $
33.17
20%
$200,000.00
4.00%
$40,000.00
1238.390093 $
32.30
4.00%
$40,000.00
800.9611534 $
49.94
4.00%
$40,000.00
955.566173 $
41.86
4.00%
$40,000.00
1566.784175 $
25.53
4.00%
$40,000.00
563.2216277 $
71.02
5%
$50,000.00
2.50%
$25,000.00
49.35834156 $
506.50
2.50%
$25,000.00
603.1363088 $
41.45
20%
$200,000.00
5.00%
$50,000.00
356.353788 $
140.31
5.00%
$50,000.00
672.8569506 $
74.31
5.00%
$50,000.00
624.0639041 $
80.12
5.00%
$50,000.00
572.3443223 $
87.36
5%
$50,000.00
1.00%
$10,000.00
178.2531194 $
56.10
1.00%
$10,000.00
3745.318352 $
2.67
1.00%
$10,000.00
90909.09091 $
0.11
1.00%
$10,000.00
379.9392097 $
26.32
1.00%
$10,000.00
52631.57895 $
0.19
Current Price
$
$
$
87.84
73.98
81.30
$
$
$
$
$
Return YTD
Current $ Amount
44% $
35% $
50% $
47,937.13
44,934.40
50,092.42
58.50
50.23
58.18
122.96
50.21
19%
33%
33%
26%
21%
$
$
$
$
$
47,735.62
53,069.20
53,388.39
50,213.37
48,383.52
$
$
$
$
$
38.74
39.37
12.88
20.94
40.83
26%
25%
36%
67%
23%
$
$
$
$
$
50,557.91
49,898.61
54,231.58
66,794.26
49,237.26
$
$
$
$
$
33.72
52.09
47.49
28.24
86.95
4%
4%
13%
11%
22%
$
$
$
$
$
41,758.51
41,722.07
45,379.84
44,245.99
48,972.12
$
$
385.17
53.62
-24% $
29% $
19,011.35
32,340.17
$
$
$
$
201.94
60.98
145.40
112.90
44%
-18%
81%
29%
$
$
$
$
71,962.08
41,030.82
90,738.89
64,617.67
$
$
$
$
$
79.62
5.96
0.15
24.41
0.43
42%
123%
36%
-7%
126%
$
$
$
$
$
$
Assumptions
Portfolio Amount
14,192.51
22,322.10
13,636.36
9,274.32
22,631.58
1,290,310.06 Total
Portfolio Return (Not
Including Dividends)
29.03%
$1,000,000
Stock Quotes Provided by MSN Money

Click here to visit MSN Money
Last
Previous
Close
High
Low
Volume
Change
% Change
52 Wk High
52 Wk Low
Market Cap
EPS
P/E Ratio
WellPoint Inc
UnitedHealth Group Inc
Cigna Corp
CVS Caremark
Walgreen Co
AmerisourceBergen Corp (Holding Co)
Chart
Chart
Chart
Chart
Chart
Chart
News
News
News
News
News
News
87.84
73.98
81.3
58.5
50.23
58.18
87.38
73.35
80.34
58.62
49.49
58.13
88.08
74.23
81.75
58.87
50.6
58.33
87.14
73.14
80.31
58.02
49.82
57.88
980,982
2,324,944
1,075,200
3,039,063
3,931,208
656,390
0.46
0.63
0.96
-0.12
0.74
0.05
0.52%
0.86%
1.19%
-0.20%
1.50%
0.09%
90
74.23
81.75
62.36
51.62
59.75
53.69
51.09
45.36
44.33
31.88
37.12
26,251,708,685
75,235,779,576
22,994,805,505
71,871,894,647
47,476,984,883
13,435,097,921
9.18
5.26
5.05
3.37
2.28
2.44
9.57
14.07
16.1
17.34
22
23.89
McKesson Corp
Cardinal Health Inc
HCA Holdings
Community Health Systems Inc
Health Management Associates Inc Cl
A
Vanguard Health Systems
Tenet Healthcare Corp
Abbott Laboratories
Eli Lilly & Co
Merck & Co Inc
Pfizer Inc
Johnson & Johnson
Intuitive Surgical
Medtronic Inc
iShares NASDAQ Biotechnology Index
Fund
Gilead Sciences
Celgene Corporation
Amgen Inc
Illumina
Organovo
HMS Holdings Corp
Medical Marijuana I
Health Enhancemt Prd
Chart
Chart
Chart
Chart
Chart
News
News
News
News
News
122.96
50.21
38.74
39.37
12.88
123
50.24
38.51
38.87
12.8
123.45
50.78
38.92
39.58
12.9
122.53
50.17
38.44
38.8
12.83
375,511
1,267,379
4,524,379
2,426,114
2,054,969
-0.04
-0.03
0.23
0.5
0.08
-0.03%
-0.06%
0.60%
1.29%
0.59%
126.36
52.49
41.83
51.29
17.28
84.65
36.91
27.92
26.33
6.97
28,100,235,328
17,061,330,617
17,326,798,871
3,735,100,579
3,348,962,790
5.82
0.97
3.12
2.35
0.47
21.12
51.81
12.41
16.75
27.1
Chart
Chart
Chart
Chart
Chart
Chart
Chart
Chart
Chart
Chart
News
News
News
News
News
News
News
News
News
News
20.94
40.83
33.72
52.09
47.49
28.24
86.95
385.17
53.62
201.94
20.93
39.38
33.46
52.18
47.68
28.37
86.9
387.32
53.2
201.38
20.95
40.99
33.73
52.35
47.79
28.53
87.17
388.76
53.74
202.91
20.92
39.45
33.49
51.92
47.26
28.16
86.62
384.08
53.22
201.05
434,862
1,080,906
3,796,139
1,707,206
5,959,594
16,242,135
4,508,715
187,864
3,785,781
590,996
0.01
1.45
0.26
-0.09
-0.2
-0.13
0.05
-2.15
0.42
0.56
0.02%
3.68%
0.78%
-0.17%
-0.41%
-0.46%
0.06%
-0.56%
0.79%
0.28%
20.97
49.48
72.47
58.41
50.16
31.15
94.42
585.67
55.98
202.91
7.84
5.17
31.64
44.88
40.02
23.55
67.14
357.02
40.28
125.63
1,631,118,560
4,145,605,992
52,389,565,717
58,720,364,534
138,915,046,504
186,890,403,300
244,962,479,578
15,277,274,071
54,098,250,347
3,706,883,500
0.75
-0.39
2.53
4.46
1.68
1.52
4.5
17.18
3.37
0
27.91
-105.85
13.33
11.69
28.23
18.62
19.3
22.39
15.93
0
Chart
Chart
Chart
Chart
Chart
Chart
Chart
Chart
News
News
News
News
News
News
News
News
60.98
145.4
112.9
79.62
5.96
24.41
0.15
0.43
61.11
146.07
113.02
77.69
5.99
24.31
0.15
0.43
61.3
147.76
113.28
80.27
6.14
24.51
0.16
0.43
60.51
145.01
111.81
77.04
5.91
23.93
0.14
0.42
3,377,017
1,665,595
1,887,566
593,174
1,659,505
181,701
11,714,670
54,215
-0.14
-0.67
-0.12
1.93
-0.03
0.1
-0.01
0
-0.22%
-0.46%
-0.11%
2.48%
-0.50%
0.41%
-4.22%
1.14%
79.37
149.92
116.25
83.23
8.5
35.73
0
0
39.21
70.66
80.6
41.74
1.8
18.5
0
0
93,613,087,444
59,927,027,271
85,121,718,055
10,005,908,857
457,229,196
2,146,882,764
78,532,651
47,529,953
1.78
3.58
5.93
0.85
-1.01
0.54
0
-0.07
34.2
40.67
19.04
94.52
-5.35
45.24
0
0
Symbol Lookup
Find stocks, mutual funds, options,
indices, and currencies.
MSN Money Home

Discover MSN Money's tools,
columns, and more!
Microsoft Office Tools on the Web

Get the latest from Microsoft Office
Terms of Use. 2013 Microsoft Corporation and/or its suppliers. All rights reserved.
DATA PROVIDERS
Copyright 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated
otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data
provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
# Shares Out
298,960,354
1,016,699,724
282,839,284
1,228,369,418
945,003,680
230,903,118
228,624,484
339,461,413
447,200,900
94,811,539
260,214,669
77,932,086
101,607,990
1,554,125,355
1,126,637,846
2,926,375,532
6,620,299,870
2,818,073,863
40,161,022
1,007,500,635
18,350,000
1,530,626,021
411,276,009
753,356,209
125,120,781
76,507,069
87,807,066
946,575,818
109,289,384
s, except where indicated

y Verus Analytics. IPO data
Insurance
WLP
Market Cap (intraday)5:
Enterprise Value (Sep 5, 2013)3:
Trailing P/E (ttm, intraday):
Forward P/E (fye Dec 31, 2014)1:
PEG Ratio (5 yr expected)1:
Price/Sales (ttm):
Price/Book (mrq):
Enterprise Value/Revenue (ttm)3:
Enterprise Value/EBITDA (ttm)6:
Financial Highlights
Fiscal Year
Fiscal Year Ends:
Most Recent Quarter (mrq):
Profitability
Profit Margin (ttm):
Operating Margin (ttm):
Management Effectiveness
Return on Assets (ttm):
Return on Equity (ttm):
Income Statement
Revenue (ttm):
Revenue Per Share (ttm):
Qtrly Revenue Growth (yoy):
Gross Profit (ttm):
EBITDA (ttm)6:
Net Income Avl to Common (ttm):
Diluted EPS (ttm):
Qtrly Earnings Growth (yoy):
Balance Sheet
Total Cash (mrq):
Total Cash Per Share (mrq):
Total Debt (mrq):
Total Debt/Equity (mrq):
Current Ratio (mrq):
Book Value Per Share (mrq):
Cash Flow Statement
Operating Cash Flow (ttm):
Levered Free Cash Flow (ttm):
26.26B
20.61B
9.57
10.39
0.91
0.39
1.07
0.31
3.63
UNH
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
Fiscal Year Ends:
31-Dec
30-Jun-13 Profitability
4.28%
7.32% Management Effectiveness
5.32%
11.79% Income Statement
Revenue (ttm):
66.37B
216.55 Gross Profit (ttm):
15.50% EBITDA (ttm)6:
13.50B
5.68B
Diluted EPS (ttm):
2.84B
9.17
24.30% Balance Sheet
Total Cash (mrq):
20.45B
Total Debt (mrq):
68.41 Total Debt/Equity (mrq):
15.51B
63.23 Book Value Per Share (mrq):
1.8
81.95 Cash Flow Statement
2.38B
2.24B
75.22B
80.27B
14.09
12.67
1.48
0.64
2.35
0.69
7.87
CI
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
31-Dec Fiscal Year Ends:
30-Jun-13 Most Recent Quarter (mrq):
22.99B
24.03B
16.35
11.21
1.11
0.73
2.33
0.77
6.46
31-Dec
30-Jun-13
Profitability
4.65% Profit Margin (ttm):
7.92% Operating Margin (ttm):
4.61%
10.74%
7.53% Return on Assets (ttm):
17.80% Return on Equity (ttm):
116.82B
114.98
11.50%
30.39B
10.20B
5.43B
5.25
7.40%
Income Statement
Revenue (ttm):
Gross Profit (ttm):
EBITDA (ttm)6:
Diluted EPS (ttm):
Balance Sheet
Total Cash (mrq):
9.93 Total Cash Per Share (mrq):
16.72B
Total Debt (mrq):
52 Total Debt/Equity (mrq):
0.68 Current Ratio (mrq):
10.10B
3.91B
3.17B
Cash Flow Statement

3.89%
15.22%
31.11B
109.7
7.50%
11.22B
3.72B
1.43B
4.97
32.90%
3.51B
12.41
5.19B
52.52
1.07
34.48
-250.00M
-374.25M
Drug Distributors
CVS
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
Fiscal Year Ends:
71.78B
79.34B
17.36
13.15
1.04
0.58
1.85
0.64
8.24
Cash Flow Statement

21.98
14.19
1.22
0.66
2.46
0.68
10.46
ABC
Forward P/E (fye Sep 30, 2014)1:
Price/Sales (ttm):
Price/Book (mrq):
13.43B
13.02B
25.32
15.81
1.37
0.16
5.55
0.16
10.23
MCK
Forward P/E (fye Mar 31, 2015)1:
Price/Sales (ttm):
Price/Book (mrq):
28.11B
29.76B
21.12
13.19
1.12
0.23
3.8
0.24
9.62
CAH
Forward P/E (fye Jun 30, 2015)1:
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
31-Aug Fiscal Year Ends:
31-May-13 Most Recent Quarter (mrq):
Fiscal Year
30-Sep Fiscal Year Ends:
Fiscal Year
31-Mar Fiscal Year Ends:
Profitability
Profitability
Profitability
Profitability
Balance Sheet
Total Cash (mrq):
Total Debt (mrq):
47.48B
48.32B
Fiscal Year
Profitability
Income Statement
Revenue (ttm):
Gross Profit (ttm):
EBITDA (ttm)6:
Diluted EPS (ttm):
WAG
Forward P/E (fye Aug 31, 2014)1:
Price/Sales (ttm):
Price/Book (mrq):
123.63B
99.58
1.70%
22.51B
9.63B
4.22B
3.37
16.00%
Income Statement
Revenue (ttm):
Gross Profit (ttm):
EBITDA (ttm)6:
Diluted EPS (ttm):
Balance Sheet
Total Cash (mrq):
9.38B
Total Debt (mrq):
1.18B
5.20B
3.01B
Cash Flow Statement

Income Statement
Revenue (ttm):
76.55 Revenue Per Share (ttm):
3.20% Qtrly Revenue Growth (yoy):
20.34B
Gross Profit (ttm):
4.62B
EBITDA (ttm)6:
2.15B
2.29 Diluted EPS (ttm):
16.20% Qtrly Earnings Growth (yoy):
71.35B
Balance Sheet
Total Cash (mrq):
6.37B
Total Debt (mrq):
3.01B
3.95B
2.44B
Cash Flow Statement

83.96B
358.56
13.30%
2.67B
1.27B
580.15M
2.3
-7.10%
Income Statement
Revenue (ttm):
Gross Profit (ttm):
EBITDA (ttm)6:
Diluted EPS (ttm):
Balance Sheet
Total Cash (mrq):
1.40B
Total Debt (mrq):
1.57B
1.36B
1.46B
Cash Flow Statement

17.04B
19.03B
51.99
12.69
1.34
0.17
2.85
0.19
7.79
30-Jun
30-Jun-13
0.33%
2.02%
123.96B
532.61
4.90%
6.98B
3.09B
1.38B
5.82
11.60%
Income Statement
Revenue (ttm):
Gross Profit (ttm):
EBITDA (ttm)6:
Diluted EPS (ttm):
Balance Sheet
Total Cash (mrq):
4.87B
Total Debt (mrq):
2.90B
3.75B
2.17B
Cash Flow Statement

5.11%
5.48%
101.09B
296.46
-5.00%
4.92B
2.44B
335.00M
0.97
N/A
1.90B
5.6
3.86B
64.69
1.22
17.63
1.73B
1.52B
Hospitals
HCA
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
Fiscal Year Ends:
17.33B
45.08B
12.42
10.28
1.02
0.52
N/A
1.35
7.09
Fiscal Year
Profitability
Income Statement
Revenue (ttm):
Gross Profit (ttm):
EBITDA (ttm)6:
Diluted EPS (ttm):
CYH
Price/Sales (ttm):
Price/Book (mrq):
N/A
3.67B
13.04B
16.8
10.18
1.26
0.28
1.22
1
7.63
HMA
Price/Sales (ttm):
Price/Book (mrq):
3.35B
7.01B
27.62
16.5
1.91
0.57
3.07
1.2
7.95
VHS
Forward P/E (fye Jun 30, 2015)1:
Price/Sales (ttm):
Price/Book (mrq):
1.63B
4.00B
27.87
20.72
3.33
0.27
4.15
0.67
7.62
THC
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
Fiscal Year
Fiscal Year
30-Jun Fiscal Year Ends:
Profitability
Profitability
Profitability
Profitability
Income Statement
Revenue (ttm):
27.30B
Gross Profit (ttm):
6.36B
EBITDA (ttm)6:
1.44B
33.39B
Balance Sheet
Total Cash (mrq):
Total Debt (mrq):
528.00M
1.18
28.52B
N/A
1.29
-19.74
Balance Sheet
Total Cash (mrq):
Total Debt (mrq):
Cash Flow Statement

3.47B
1.29B
Cash Flow Statement

13.04B
143.65
-0.20%
11.06B
1.71B
215.73M
2.34
-64.30%
Income Statement
Revenue (ttm):
Gross Profit (ttm):
EBITDA (ttm)6:
Diluted EPS (ttm):
Balance Sheet
Total Cash (mrq):
9.63B
Total Debt (mrq):
251.23M
1.11B
225.36M
Cash Flow Statement

Income Statement
Revenue (ttm):
-0.50% Qtrly Revenue Growth (yoy):
5.88B
Gross Profit (ttm):
882.06M
EBITDA (ttm)6:
123.30M
-80.10% Qtrly Earnings Growth (yoy):
5.87B
Balance Sheet
Total Cash (mrq):
3.73B
Total Debt (mrq):
85.91M
432.62M
70.53M
Cash Flow Statement

4.15B
9.57B
N/A
13.12
2.02
0.43
4.48
1.02
7.92
31-Dec
30-Jun-13
-0.51%
7.97%
Income Statement
Revenue (ttm):
N/A
3.89B
Gross Profit (ttm):
525.30M
EBITDA (ttm)6:
59.80M
N/A
6.00B
624.00M
8.01
3.00B
640.49
1.65
5.05
Balance Sheet
Total Cash (mrq):
Total Debt (mrq):
300.80M
29.27M
Cash Flow Statement

5.29%
-2.78%
9.36B
89.73
6.90%
7.57B
1.21B
-53.00M
-0.49
N/A
90.00M
0.89
5.64B
531.1
1.55
8.8
520.00M
364.12M
Pharmaceuticals
ABT
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
Fiscal Year Ends:
52.41B
50.96B
13.45
15.12
1.4
1.3
2.33
1.27
4.42
LLY
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
56.27B
56.17B
11.71
18.82
-3.43
2.46
3.7
2.45
8.17
MRK
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
Profitability
Profitability
Profitability
Income Statement
Revenue (ttm):
Gross Profit (ttm):
EBITDA (ttm)6:
Diluted EPS (ttm):
Balance Sheet
Total Cash (mrq):
Total Debt (mrq):
Cash Flow Statement
Income Statement
Revenue (ttm):
24.75B
Gross Profit (ttm):
11.54B
EBITDA (ttm)6:
6.19B
-72.40% Qtrly Earnings Growth (yoy):
40.10B
Balance Sheet
Total Cash (mrq):
7.93B
Total Debt (mrq):
9.39B
6.20B
6.88B
Cash Flow Statement

Income Statement
Revenue (ttm):
17.81B
Gross Profit (ttm):
6.88B
EBITDA (ttm)6:
4.91B
22.93B
Balance Sheet
Total Cash (mrq):
5.31B
Total Debt (mrq):
4.72B
5.16B
3.84B
Cash Flow Statement

138.97B
147.88B
28.43
12.9
5.02
3.11
2.94
3.29
9.67
PFE
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
Profitability
44.91B
14.87
-10.60%
30.82B
15.29B
5.14B
1.67
-49.50%
Income Statement
Revenue (ttm):
Gross Profit (ttm):
EBITDA (ttm)6:
Diluted EPS (ttm):
Balance Sheet
Total Cash (mrq):
28.14B
Total Debt (mrq):
18.10B
9.63B
8.99B
Cash Flow Statement

186.98B
189.27B
7.83
12.27
4.29
3.32
2.39
3.35
7.69
JNJ
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
245.05B
233.81B
19.31
14.94
2.55
3.5
3.51
3.34
10.28
30-Dec
30-Jun-13
Profitability
18.38%
26.68%
9.72%
19.26%
56.56B
7.81
-7.10%
47.65B
24.60B
11.09B
3.6
333.30%
Income Statement
Revenue (ttm):
Gross Profit (ttm):
EBITDA (ttm)6:
Diluted EPS (ttm):
Balance Sheet
Total Cash (mrq):
36.94B
Total Debt (mrq):
33.78B
16.33B
18.09B
Cash Flow Statement

69.99B
25.16
8.50%
45.57B
22.74B
12.86B
4.51
172.20%
25.13B
8.92
14.98B
21.51
2.16
24.75
15.68B
12.14B
Medical Devices
ISRG
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
Fiscal Year Ends:
15.28B
13.98B
22.37
22.05
1.85
6.58
4.13
5.98
14.09
MDT
Forward P/E (fye Apr 26, 2015)1:
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
54.14B
52.18B
15.48
13.1
2.15
3.22
2.9
3.13
9.26
26-Apr
26-Jul-13
Profitability
Profitability
21.34%
28.85%
8.82%
19.88%
Income Statement
Revenue (ttm):
Gross Profit (ttm):
EBITDA (ttm)6:
Diluted EPS (ttm):
Balance Sheet
Total Cash (mrq):
Total Debt (mrq):
Cash Flow Statement
Income Statement
Revenue (ttm):
1.57B
Gross Profit (ttm):
992.40M
EBITDA (ttm)6:
706.20M
2.34B
1.29B
N/A
Balance Sheet
Total Cash (mrq):
0 Total Debt (mrq):
885.50M
643.45M
Cash Flow Statement

16.66B
16.43
1.90%
12.46B
5.64B
3.56B
3.47
10.30%
11.33B
11.22
11.18B
60.37
4.25
18.34
4.58B
3.67B
Biotechnology
GILD
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
Fiscal Year Ends:
93.33B
97.30B
34.25
20.4
1.13
9.07
8.42
9.43
21.87
CELG
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
59.81B
58.22B
40.75
20.21
1.08
10.13
11.11
9.82
23.28
AMGN
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
85.05B
83.91B
19.04
13.79
1.69
4.82
4.13
4.75
11.88
31-Dec
30-Jun-13
Profitability
Profitability
Profitability
25.98%
33.70%
7.10%
23.03%
Income Statement
Revenue (ttm):
Gross Profit (ttm):
EBITDA (ttm)6:
Diluted EPS (ttm):
Balance Sheet
Total Cash (mrq):
Total Debt (mrq):
Cash Flow Statement
Income Statement
Revenue (ttm):
7.23B
Gross Profit (ttm):
4.45B
EBITDA (ttm)6:
2.93B
10.31B
Balance Sheet
Total Cash (mrq):
7.34B
Total Debt (mrq):
2.29B
3.08B
2.28B
Cash Flow Statement

Income Statement
Revenue (ttm):
5.21B
Gross Profit (ttm):
2.50B
EBITDA (ttm)6:
1.55B
5.93B
Balance Sheet
Total Cash (mrq):
3.67B
Total Debt (mrq):
4.08B
2.16B
1.81B
Cash Flow Statement

17.66B
23.25
4.50%
14.35B
7.06B
4.59B
5.93
-0.60%
22.02B
29.23
23.92B
116.13
6.2
27.35
5.18B
2.46B
High Risk
ILMN
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
Fiscal Year Ends:
9.96B
9.46B
94.12
39.41
2.66
7.64
7
7.44
27.26
Fiscal Year
Profitability
Profitability
Income Statement
Revenue (ttm):
Gross Profit (ttm):
EBITDA (ttm)6:
Diluted EPS (ttm):
Balance Sheet
Total Cash (mrq):
Total Debt (mrq):
Cash Flow Statement
ONVO
Forward P/E (fye Mar 31, 2015)1:
Price/Sales (ttm):
Price/Book (mrq):
1.27B
10.3
23.30%
773.53M
347.06M
114.94M
0.85
53.30%
Income Statement
Revenue (ttm):
Gross Profit (ttm):
EBITDA (ttm)6:
Diluted EPS (ttm):
9.03
851.90M
61.35
3.93
11.1
Balance Sheet
Total Cash (mrq):
Total Debt (mrq):
306.55M
241.88M
Cash Flow Statement

1.13B
455.22M
424.03M
39.6
N/A
N/A
402.35
56.51
372.28
-39.38
MJNA
Forward P/E (fye )1:
Price/Sales (ttm):
Price/Book (mrq):
138.06M
135.00M
N/A
N/A
N/A
N/A
4.97
NaN
N/A
HMSY
Price/Sales (ttm):
Price/Book (mrq):
2.14B
2.37B
45.28
22.64
1.42
4.37
4.31
4.84
15.84
HEPI
Price/Sales (ttm):
Price/Book (mrq):
Fiscal Year
31-Mar Fiscal Year Ends:
Fiscal Year
N/A
Fiscal Year Ends:
31-Mar-13 Most Recent Quarter (mrq):
Profitability
-974.44% Operating Margin (ttm):
N/A
N/A
Profitability
Profitability
N/A
N/A
N/A
N/A
-367.93%
N/A
N/A
N/A
1.14M
0.02
-59.10%
1.20M
-10.77M
9.02M
0.15
N/A
Income Statement
Revenue (ttm):
Gross Profit (ttm):
EBITDA (ttm)6:
Diluted EPS (ttm):
Balance Sheet
Total Cash (mrq):
22.00K
Total Debt (mrq):
12.85M
-9.69M
N/A
Cash Flow Statement

Income Statement
Revenue (ttm):
-6.80% Qtrly Revenue Growth (yoy):
N/A
Gross Profit (ttm):
N/A
EBITDA (ttm)6:
N/A
N/A
Diluted EPS (ttm):
N/A
N/A
14.76M
N/A
N/A
N/A
N/A
Balance Sheet
Total Cash (mrq):
0 Total Debt (mrq):
Cash Flow Statement
Fiscal Year
47.53M
49.78M
N/A
N/A
N/A
N/A
N/A
NaN
-20.27
488.73M
5.62
4.80%
154.79M
149.34M
47.89M
0.54
-19.70%
Income Statement
Revenue (ttm):
Gross Profit (ttm):
EBITDA (ttm)6:
Diluted EPS (ttm):
Balance Sheet
Total Cash (mrq):
302.80M
Total Debt (mrq):
5 Current Ratio (mrq):
131.47M
82.29M
74.76M
Cash Flow Statement

31-Dec
30-Jun-13
N/A
N/A
N/A
N/A
-2.46M
-7.12M
-0.07
N/A
254.60K
0
1.95M
N/A
0.06
-0.08
-2.23M
5.34M

ACA Portfolio, Winners and Losers Affordable Care Act (ObamaCare)

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

ACA Portfolio, Winners and Losers Affordable Care Act (ObamaCare)

Uploaded by

Copyright:

Available Formats

Stock Symbol

Portfolio % Dollar Amount

Stock Quotes Provided by MSN Money

MSN Money Home

Microsoft Office Tools on the Web

s, except where indicated

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

Cash Flow Statement

You might also like